Archive for June, 2009
« Previous Entries Next Entries »Fluorouracil may help repair sun damage, wrinkles, research suggests.
Tuesday, June 16th, 2009Bloomberg News (6/16, Ostrow) reports that, according to a study published in the June issue of the journal Archives of Dermatology, “a skin cream containing” the chemotherapy medicine fluorouracil, which “treats precancerous skin patches, also reduced sun damage and wrinkles on the faces of 21 people who used the drug.” Researchers from the University of [...]
New Data Confirm That Diovan(R) And Valsartan-Based Combinations Offer Patients Sustained, 24-hr BP-lowering Efficacy
Monday, June 15th, 2009Data presented at the 19th Scientific Meeting of the European Society of Hypertension (ESH) confirm that Diovan® (valsartan) and valsartan-based combinations deliver sustained, 24-hr blood pressure (BP)-lowering efficacy2-6.
Studies have suggested that the relative risks of acute myocardial infarction, stroke and sudden cardiac death are 40%, 49% and 29% higher, respectively, when the period between 6 [...]
Newly Analyzed Data Show Daily Treatment With Nasonex Significantly Reduces Symptom Recurrence In Patients With Perennial Allergic Rhinitis
Friday, June 12th, 2009Recently analyzed data demonstrate the benefits of adhering to a daily NASONEX® (mometasone furoate monohydrate) Nasal Spray, 50 mcg* treatment regimen following initial symptom relief, including longer sustained relief of nasal symptoms and significantly fewer recurrences, compared with placebo. Results from this post hoc analysis of four Phase III clinical studies of adult patients with [...]
Statins May Play a Role in Myocardial Hemodynamics
Thursday, June 11th, 2009Familial hypercholesterolemia adversely affected myocardial blood flow, which improved significantly with atorvastatin (Lipitor), according to data from a small study.
The patients had reduced myocardial blood flow reserve caused primarily by augmented resting myocardial blood flow, Fabio C. Lario, M.D., of the Heart Institute (InCor) in Sao Paulo, Brazil, and colleagues reported here at the American [...]
New osteoporosis treatment offers proven fracture protection and added convenience
Thursday, June 11th, 2009Canadians with postmenopausal osteoporosis have a new treatment option that provides proven protection against fractures, with a convenient, once-a-month dosing regimen. Actonel 150 mg is the first and only once-a-month dosing option available in Canada for the treatment of postmenopausal osteoporosis.
“Many of my osteoporosis patients have asked me about the availability of a once-a-month dosing [...]
More patients with type 2 diabetes reach target lipid levels with combination therapy
Tuesday, June 9th, 2009Source: Modern Medicine.com
A significantly greater proportion of patients with type 2 diabetes with mixed dyslipidemia treated with a combination of fenofibric acid and rosuvastatin achieved American Diabetes Association (ADA) target lipid levels compared to those taking rosuvastatin alone, reports Robert S. Rosenson, MD, State University of New York, Brooklyn, NY (pictured left). “Because diabetes is [...]
Filling in the Medicare doughnut hole is a sticky issue
Tuesday, June 9th, 2009AARP and other advocates for older adults are calling on Congress to get rid of the “doughnut hole” in Medicare’s drug benefit as part of the lawmakers’ broader efforts to reform health care.
Though most seniors say they’re pleased with the drug benefit, the one aspect they love to hate is the gap in coverage that [...]
Patients Cut Medication Costs in Half
Monday, June 8th, 2009People who take prescription medications may be able to save money by asking their physician for a larger dose and splitting the pills in half.
“If you’re trying to make a choice about what you spend money on and you’re considering going without medication because of the cost you might want to talk to your doctor [...]
FDA says three atypical antipsychotic medications may be effective in children, but carry risks.
Monday, June 8th, 2009The Wall Street Journal (6/5, Dooren) reported that on June 5, staff from the Food and Drug Administration (FDA) said that three medications “currently approved to treat bipolar disorder and schizophrenia in adults were effective at treating the disorders in children and adolescents, but carry significant risks.” The FDA is now “considering applications (pdf) for [...]
Generic drugs not as effective as brands? Show us the evidence.
Friday, June 5th, 2009Consumer Reports has long advocated the use of generic drugs because they are not only as effective and safe as their branded counterparts but cost less too. So when a segment aired last week on the Today Show that warned about the use of generic drugs to treat epilepsy and other disorders, based on a [...]
« Previous Entries Next Entries »